; table of contents. Sec. 2. Sense of the Senate. Sec. 3. Sickle cell disease surveillance. Sec. 4. Sickle cell disease prevention and treatment. Sec. 5. Collaboration with community-based entities. 2. Sense of the Senate It is the Sense of the Senate that further research should be undertaken to expand the understanding of the cause of, and to find a cure for, sickle cell disease. 3. Sickle cell disease surveillance Part P of title III of the Public Health Service Act is amended by inserting after section 399V–6 ( 42 U.S.C. 280g–17 ) the following: 399V–7. National Sickle Cell Disease Surveillance, Prevention, and Treatment Program (a) Surveillance (1) Grants The Secretary may, for each fiscal year for which appropriations are available to carry out this subsection, make grants to not more than 20 eligible entities for the following purposes: (A) To conduct surveillance and maintain data on the prevalence and distribution of sickle cell disease and its associated health outcomes, complications, and treatments. (B) To conduct public health initiatives with respect to sickle cell disease, including one or more of the following: (i) Increasing efforts to improve access to high-quality sickle cell disease-related health care, including the use of treatments approved under section 505 of the Federal Food, Drug, and Cosmetic Act or licensed under section 351 of this Act. (ii) Working with partners to improve health outcomes of people with sickle cell disease over the lifespan by promoting guidelines for sickle cell disease screening, prevention, and treatment, including management of sickle cell disease complications. (iii) Providing support to community-based organizations and State and local health departments in conducting sickle cell disease education and training activities for patients, communities, and health care providers. (iv) Supporting and training State health departments and regional laboratories in comprehensive testing to identify specific forms of sickle cell disease in people of all ages. (C) To